|
Volumn 28, Issue 5, 1997, Pages 348-354
|
Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old
a a a |
Author keywords
brain tumours; chemotherapy; children; medulloblastoma; radiotherapy
|
Indexed keywords
CARMUSTINE;
LOMUSTINE;
METHOTREXATE;
PROCARBAZINE;
TENIPOSIDE;
VINCRISTINE;
ADULT;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CLINICAL ARTICLE;
FEMALE;
GROWTH HORMONE DEFICIENCY;
HUMAN;
INFANT;
MALE;
MEDULLOBLASTOMA;
MORTALITY;
NEUROLOGICAL COMPLICATION;
POSTOPERATIVE INFECTION;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIATION DOSE;
SOCIAL ADAPTATION;
SURVIVAL RATE;
WOUND INFECTION;
ACTUARIAL ANALYSIS;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRAIN;
CEREBELLAR NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CHILD;
CHILD, PRESCHOOL;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFANT;
MALE;
MEDULLOBLASTOMA;
QUALITY OF LIFE;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
SPINAL CORD;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0030899253
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1096-911X(199705)28:5<348::AID-MPO4>3.0.CO;2-H Document Type: Article |
Times cited : (89)
|
References (23)
|